[Anti-herpetic chemotherapeutic drugs].
Shiraki
Kimiyasu
K
Department of Virology, Toyama Medical and Pharmaceutical University.
D000212:Acyclovir / Q000031:analogs & derivatives*; D000998:Antiviral Agents / Q000008:administration & dosage / Q000494:pharmacology; D004279:DNA, Viral / Q000096:biosynthesis; D024882:Drug Resistance, Viral; D017245:Foscarnet; D006564:Herpesviridae / Q000201:enzymology / Q000378:metabolism; D006566:Herpesviridae Infections / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D007065:Idoxuridine; D047428:Protein Kinase Inhibitors; D013937:Thymidine Kinase / Q000037:antagonists & inhibitors; D000077483:Valacyclovir; D014633:Valine / Q000031:analogs & derivatives*; D014740:Vidarabine
D000998:Antiviral Agents; D004279:DNA, Viral; D047428:Protein Kinase Inhibitors; D017245:Foscarnet; D013937:Thymidine Kinase; D014740:Vidarabine; D014633:Valine; D007065:Idoxuridine; D000077483:Valacyclovir; D000212:Acyclovir